Blood Clotting Factors Market Is Gaining Significant Traction With Novo Nordisk Receiving The U.S. Fda Approval For Its Biologics License Application The Treatment Of Hemophilia A

Blood Clotting Factors Market

 Blood clotting refers to the physiological process whereby red blood cells bind together with plasma (blood plasma) and stop the spread of blood from one vessel to another. Coagulation, or blood clotting, is normally the result of the thrombotic occlusion, whereby a blood clot forms in a blood vessel (venous thrombus) after it breaks, usually due to intense physical trauma or bleeding. Since there is a high yield of plasma products and has increasing number of patients with blood disorders, North America is likely to gain robust traction in the blood clotting factors market in the near future. On the contrary, Asia Pacific is exhibiting promising signs with improving healthcare infrastructure and rising disposable income in the region.

Blood clotting factors play an immense role in control the bleeding wherein blood is converted into solid lots at the time of any wound or break down of blood vessels. Over the years, regulatory authorities have approved novel drugs for blood clotting factors. Recently, in April 2020, the U.S. Food and Drug Administration (FDA), approved Sevenfact (coagulation factor VII (recombinant)-jncw] to Laboratoire Francais du Fractionnement et des Biotechnologies S.A. for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years of age and above with hemophilia A or B. Thus, such factors can potentially stimulate growth of the blood clotting factors market.

One of the common blood clotting factors is fibrinogen, which is produced by a specific enzyme (alpha-plechin) called purines. Although fibrinogen is produced by every human cell and is used in all organs including the red blood cells, it is particularly important in the clotting process. Fibrin is a complex protein consisting of two proteins namely fibrin protein and peptide chains. Regardless of these positive factors, stringent regulatory policies for product approval remain one of the major hurdles in the development of the blood clotting factors market. Besides, a shortage in plasma supply can impede growth of the market in the near future.

Another great factor that governs the demand for blood clotting factors is high prevalence of hemophilia. As per the Centers for Disease Control and Prevention (CDC), around 400 babies are born with hemophilia each year in the U.S. Such factors could lead to high growth of the blood clotting factors market in the near future. Recently, in February 2019, Novo Nordisk, a Danish drug developer, received the U.S. FDA approval for its Biologics License Application for Esperoct (turoctocog alfa pegol) formerly known as N8-GP, for the treatment of children and adults with hemophilia A.

Location: India

Comments

Post a Comment

Popular posts from this blog

Growing The Production And Sales Of Racing Cars And High-Performance Vehicles To Boost The Automotive Roller Tappets Market

Image
 Automotive roller tappets (additionally alluded to as cam supporter or valve lifter) is a little piece of equipment incorporated between valves or the camshaft flap and the valve lifting system, considering motor plan necessities. It is fundamentally a cup that gives lodging to the valve return spring and a valve stem and gives a direct movement to different segments of the vehicle. In addition, it is broadly utilized in inward burning motors, as it is utilized to change the general leeway in the valve incitation framework, permitting the camshaft to turn vertically while pivoting the camshaft in a vertical movement.  Expanding request or appropriation of VVT (variable valve timing) or double VVT are unmistakable elements driving the automotive roller tappets market development. Superior vehicles, just as dashing vehicles, track down the generous utilization of VVT innovation. Coordination of lift electronic control and variable valve timing permits the fuse of numerous cams...
Read more

Dextrin Is A Food Product That Has Properties Identical To Both Glucose And Maltodextrin

Image
 Dextrin is a complex carbohydrate polymer where one sugar molecule sets with another through a peptide security. The term comes from the way that each sugar molecule has a twofold connection between the glucose and amino gathering. The sugar in the hexose sugars (glucose) and the forward curve of the twofold bond is called 'dextrin', while the non-amylated sugar is called 'xtrin' or just 'x'. The motivation behind this carbohydrate polymer is to make a complex, instead of straightforward sugar. Dextrin was at first evolved to supplant sucrose as a food supplement (in the food business) and for medical purposes.  Dextrin contains numerous comparative properties to both glucose and maltodextrin and it was frequently utilized as a fixing to supplant sugar in diabetic weight control plans (since diabetic eating regimens regularly don't contain the complex carbohydrates that give the heft of dietary fiber). Additionally, dextrin has the benefit of looking like ...
Read more

Oligonucleotide Synthesis Market Is Witnessing Robust Growth With Agilent Technologies Announcing To Invest Us$ 150 Million To Double Its Production Capacity For Oligonucleotides In Colorado, U.S.

Image
 Oligonucleotide Synthesis is the direct physical expression of a nucleic acid chain reaction that results in the generation of a DNA sequence by random synthesis. Oligonucleotides are very long sequences of DNA that are helical in nature. Nucleic acid is the genetic material that makes up DNA, the building block of life. It is a highly complex material composed of various amino acids, sugars, and other molecules. It is a system that can be studied at the molecular level and used for biochemistry research and development. Developed countries such as the U.S. and Canada have a strong foothold in the oligonucleotide synthesis market. This is typically due to the fact there are rapid growth of genomics, oncology, diagnostic screening, and drug discovery sectors. On the contrary, emerging regions including Asia Pacific seem to be gaining major traction with rapid progress in genomics studies in the healthcare sector and rising investments.   The use of synthesized oligos in t...
Read more